‘Historic moment in cancer treatment’

(USA) A revolutionary cancer therapy has been approved by regulators in America. The US Food and Drug Administration (FDA) has given its backing for the drug developed by Novartis, called CTL019, a therapy which ‘genetically changes the cells of a cancer patient to enable them to combat the disease’. Novartis worked with University of Pennsylvania and Oxford BioMedica on … Continue reading ‘Historic moment in cancer treatment’